Cargando…
Neoadjuvant hyperfractionated accelerated radiotherapy plus concomitant 5-fluorouracil infusion in locally advanced rectal cancer: A phase II study
AIM: To evaluate the efficacy and tolerability of neoadjuvant hyperfractionated accelerated radiotherapy (HART) and concurrent chemotherapy in patients with locally advanced infraperitoneal rectal cancer. METHODS: A total of 30 patients with histopathologically confirmed T2-3/N0+ infraperitoneal ade...
Autores principales: | Gural, Zeynep, Saglam, Sezer, Yucel, Serap, Kaytan-Saglam, Esra, Asoglu, Oktar, Ordu, Cetin, Acun, Hediye, Sharifov, Rasul, Onder, Semen, Kizir, Ahmet, Oral, Ethem N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5767792/ https://www.ncbi.nlm.nih.gov/pubmed/29375747 http://dx.doi.org/10.4251/wjgo.v10.i1.40 |
Ejemplares similares
-
Successful treatment of triple primary tumor()()
por: Kurul, Sidika, et al.
Publicado: (2013) -
Outcomes of thymoma after multimodal therapy and determinants of survival: A 16-year experience of a tertiary cancer center
por: Ak, Naziye, et al.
Publicado: (2021) -
The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUV(max) on Predicting Survival in Patients with Rectal Cancer
por: Alçın, Göksel, et al.
Publicado: (2020) -
Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy
por: Sen, Fatma, et al.
Publicado: (2016) -
Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?
por: Vatankulu, Betül, et al.
Publicado: (2015)